Amphista
Edit

Amphista

https://www.amphista.com/
Last activity: 24.01.2024
Categories: BioTechClinicDrugHealthTechOwnPlatformScience
A new approach to protein degradation – At Amphista Therapeutics we are developing drugs to bring life-changing medicines to patients. Powered by transformational science we are advancing beyond traditional degrader approaches.
Mentions
7
Location: United Kingdom, Scotland, Chapelhall
Total raised: $60.5M

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
17.03.2021Series B$53MGilde Heal...
07.04.2020Series A$7.5M-

Mentions in press and media 7

DateTitleDescriptionSource
24.01.2024Amphista Therapeutics announces new data demonstrating in vi...Cambridge, UK, January 24th, 2024 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in...svhealthin...
24.01.2024Amphista Therapeutics announces new data demonstrating in vi...• First demonstration of efficacy in disease-relevant in vivo models for an orally delivered bifunct...forbion.co...
13.12.2022Dementia Discovery Fund invests in Amphista Therapeutics as ...Cambridge, UK – December 13, 2022 – Amphista Therapeutics, a leader in next generation targeted prot...svhealthin...
17.03.2021Amphista Therapeutics raises $53M in Series B round co-led b...Glasgow, UK - Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) ...gildehealt...
17.03.2021Amphista Therapeutics Raises $53M in Series B FundingAmphista Therapeutics, a Glasgow, Scotland, UK-based leader in next generation targeted protein degr...finsmes.co...
08.04.2020Daily funding roundup - April 7th, 2020Cyolo has raised $4.2M; Amphista Therapeutics secured $7.5M; Neat landed $11M Cyolo: Cyolo is a unif...vator.tv/n...
07.04.2020Amphista Therapeutics Raises $7.5M in Series A FundingAmphista Therapeutics, a Glasgow, Scotland-based biopharmaceutical company, closed a USD $7.5m Serie...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In